Natera (NTRA) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates

27.02.26 00:30 Uhr

Werte in diesem Artikel
Aktien

172,00 EUR 0,00 EUR 0,00%

For the quarter ended December 2025, Natera (NTRA) reported revenue of $665.5 million, up 39.8% over the same period last year. EPS came in at $0.35, compared to -$0.41 in the year-ago quarter.The reported revenue compares to the Zacks Consensus Estimate of $660.45 million, representing a surprise of +0.76%. The company delivered an EPS surprise of +175.43%, with the consensus EPS estimate being -$0.46.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.Here is how Natera performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:Volume - Tests processed: 923,600 versus the three-analyst average estimate of 903,207.Revenues- Licensing and other: $4.34 million versus $2.32 million estimated by four analysts on average. Compared to the year-ago quarter, this number represents a +37.7% change.Revenues- Product: $661.16 million versus $570.94 million estimated by four analysts on average. Compared to the year-ago quarter, this number represents a +39.8% change.View all Key Company Metrics for Natera here>>>Shares of Natera have returned -10.2% over the past month versus the Zacks S&P 500 composite's +0.6% change. The stock currently has a Zacks Rank #4 (Sell), indicating that it could underperform the broader market in the near term.Just Released: Zacks Top 10 Stocks for 2026Hurry – you can still get in early on our 10 top tickers for 2026. Handpicked by Zacks Director of Research Sheraz Mian, this portfolio has been stunningly and consistently successful.From inception in 2012 through November, 2025, the Zacks Top 10 Stocks gained +2,530.8%, more than QUADRUPLING the S&P 500’s +570.3%.Sheraz has combed through 4,400 companies covered by the Zacks Rank and handpicked the best 10 to buy and hold in 2026. You can still be among the first to see these just-released stocks with enormous potential.See New Top 10 Stocks >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Natera, Inc. (NTRA): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

In eigener Sache

Übrigens: Natera und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und Neukunden-Bonus sichern!

Quelle: Zacks

Nachrichten zu Q4 Inc Registered Shs Unitary